ATE228008T1 - Herpesvirus impfstoffe - Google Patents

Herpesvirus impfstoffe

Info

Publication number
ATE228008T1
ATE228008T1 AT93918571T AT93918571T ATE228008T1 AT E228008 T1 ATE228008 T1 AT E228008T1 AT 93918571 T AT93918571 T AT 93918571T AT 93918571 T AT93918571 T AT 93918571T AT E228008 T1 ATE228008 T1 AT E228008T1
Authority
AT
Austria
Prior art keywords
herpesvirus
herpes virus
mammal
virus vaccines
virus
Prior art date
Application number
AT93918571T
Other languages
English (en)
Inventor
David Knipe
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25447772&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE228008(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Harvard College filed Critical Harvard College
Application granted granted Critical
Publication of ATE228008T1 publication Critical patent/ATE228008T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Arrangement Or Mounting Of Propulsion Units For Vehicles (AREA)
  • Combined Devices Of Dampers And Springs (AREA)
  • Saccharide Compounds (AREA)
AT93918571T 1992-07-31 1993-08-02 Herpesvirus impfstoffe ATE228008T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92291292A 1992-07-31 1992-07-31
PCT/US1993/007245 WO1994003207A1 (en) 1992-07-31 1993-08-02 Herpesvirus vaccines

Publications (1)

Publication Number Publication Date
ATE228008T1 true ATE228008T1 (de) 2002-12-15

Family

ID=25447772

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93918571T ATE228008T1 (de) 1992-07-31 1993-08-02 Herpesvirus impfstoffe

Country Status (6)

Country Link
EP (1) EP0652772B2 (de)
JP (1) JP4044131B2 (de)
AT (1) ATE228008T1 (de)
CA (1) CA2141574C (de)
DE (1) DE69332501T3 (de)
WO (1) WO1994003207A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837261A (en) * 1990-09-25 1998-11-17 Cantab Pharmaceuticals Research Limited Viral vaccines
AU658836B2 (en) 1990-09-25 1995-05-04 Xenova Research Limited Viral defective vaccine produced by transcomplementing cell line
US5665362A (en) * 1990-09-25 1997-09-09 Cantab Pharmaceuticals Research Limited Viral vaccines
US20020009462A1 (en) * 1992-07-31 2002-01-24 David M. Knipe Herpesvirus replication defective mutants
US7223411B1 (en) 1992-07-31 2007-05-29 Dana-Farber Cancer Institute Herpesvirus replication defective mutants
US6471965B1 (en) * 1994-07-27 2002-10-29 Bio-Virus Research Incorporated Vaccine containing whole killed herpes viruses to prevent development of atherosclerotic plaque
GB9415369D0 (en) * 1994-07-29 1994-09-21 Lynxvale Ltd Mutant virus
ES2264136T3 (es) * 1995-02-21 2006-12-16 Cantab Pharmaceuticals Research Limited Preparaciones virales, vectores, inmunogenos y sus vacunas.
CA2234877A1 (en) * 1995-10-19 1997-04-24 St. Jude Children's Research Hospital Herpesvirus vectors and their uses
GB9615794D0 (en) 1996-07-26 1996-09-04 Medical Res Council Mutant herpes simplex virus strains and uses thereof
US6399354B1 (en) 1998-07-31 2002-06-04 President And Fellows Of Harvard College Replication-competent virus expressing a detectable fusion protein
GB9816781D0 (en) * 1998-07-31 1998-09-30 Univ London Herpes virus vectors for dendritic cells
US7063851B2 (en) 2000-04-12 2006-06-20 Biovex Limited Herpes viruses for immune modulation
DK2943567T3 (en) * 2013-01-08 2018-01-02 Genzyme Corp USE OF INOS INHIBITORS TO INCREASE VIRAL YIELD IN CULTURE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859587A (en) * 1984-06-04 1989-08-22 Institut Merieux Recombinant herpes simplex viruses, vaccines and methods
CA2039921A1 (en) * 1990-04-16 1991-10-17 Xandra O. Breakefield Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
AU658836B2 (en) * 1990-09-25 1995-05-04 Xenova Research Limited Viral defective vaccine produced by transcomplementing cell line

Also Published As

Publication number Publication date
EP0652772A4 (de) 1996-05-29
JP4044131B2 (ja) 2008-02-06
DE69332501T3 (de) 2009-03-26
DE69332501D1 (en) 2003-01-02
DE69332501T2 (de) 2003-10-09
CA2141574C (en) 2009-11-24
CA2141574A1 (en) 1994-02-17
WO1994003207A1 (en) 1994-02-17
JPH08502043A (ja) 1996-03-05
EP0652772B1 (de) 2002-11-20
EP0652772A1 (de) 1995-05-17
EP0652772B2 (de) 2008-07-23

Similar Documents

Publication Publication Date Title
DE69332501D1 (en) Herpesvirus impfstoffe
Whitley et al. Herpes simplex viruses: is a vaccine tenable?
DK157087A (da) Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus
US9546355B2 (en) Conditional replicating cytomegalovirus as a vaccine for CMV
ATE295895T1 (de) Genetischer impfstoff gegen den immunschwäche virus
WO1994021807A3 (en) Defective mutant non-retroviral virus (e.g. hsv) as vaccine
HUP0102478A2 (hu) A HCV-burokfehérjék által alkotott részecskék alkalmazása vakcinázásban
ES8406199A1 (es) Procedimiento para aislar un preparado inmunologicamente activo de glicoproteina gd-1 con envoltura de virus de herpes simplex de tipo 1.
DE3786824D1 (de) Rekombinante herpes simplex-viren, vakzine und verfahren.
EP0232798A3 (de) Pseudorabies-Virus-Mutanten, diese enthaltende Vakzine, Verfahren zu deren Herstellung sowie Methoden für deren Anwendung
ATE360061T1 (de) Replikationsmangelhafte mutanten von herpesvirus
AU6489986A (en) Thymidine kinase deletion mutants of bovine herpersvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same
DK0956045T3 (da) Samlingsdeficient herpesvirusvaccine
AU2403188A (en) Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
DE69933875D1 (de) Protein-verabreichungssystem, das dem menschlichen papillomavirus ähnliche partikel benützt.
Nesburn et al. Ocular safety and efficacy of an HSV-1 gD vaccine during primary and latent infection.
OA09863A (en) Use of IL-4 to enhance immune response to immunogens in vaccines.
TR200102168T2 (tr) BHV-1 geni silinmiş virüs aşısı.
Ferenczy Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virus
DE69232858D1 (de) Herpesvirus-partikel zubereitung und vakzine
DE2962921D1 (en) Feline infectious peritonitis vaccine and process for its preparation
Xiao et al. Experimental studies of a human diploid cell rabies vaccine for human use.
Chow et al. Antigenic determinants in the poliovirus capsid protein VP 1.
RU97115149A (ru) Способ вакцинации против вирусного гепатита в
Husson-van Vliet Comparison of two cellular supports for control of the temperature marker of attenuated poliovirus strains.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties